A comparison of cathartics in pediatric ingestions

L P James1, M H Nichols, W D King

  • 1Department of Pediatrics, University of Alabama at Birmingham, USA.

Pediatrics
|August 1, 1995
PubMed

Insights

In pediatric ingestions, sorbitol with activated charcoal significantly reduced the time to the first stool and increased stool frequency compared to other cathartics. However, sorbitol also led to more instances of emesis.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Cathartics are frequently used in pediatric ingestions to enhance elimination of toxic substances.
  • Limited comparative data exists on the efficacy and safety of commonly used cathartics in this population.

Purpose of the Study:

  • To compare the efficacy of sorbitol, magnesium citrate, and magnesium sulfate as cathartics in pediatric acute ingestions.
  • To evaluate the time to first stool, stool frequency, and incidence of side effects.

Main Methods:

  • A prospective, randomized, double-blinded clinical trial involving pediatric patients aged 1 to 5 years with acute ingestions.
  • Patients received activated charcoal with either sorbitol, magnesium citrate, magnesium sulfate, or water.
  • Outcomes measured included mean time to first stool and mean number of stools within 24 hours.

Main Results:

  • Sorbitol administration resulted in a significantly shorter mean time to the first stool (8.48 hours) compared to other agents.
  • Sorbitol also produced a significantly higher mean number of stools (2.79) in the 24-hour period.
  • Emesis was the most frequent side effect, occurring more often in the sorbitol group.

Conclusions:

  • Sorbitol is an effective cathartic in pediatric acute ingestions, promoting faster and more frequent bowel movements when combined with activated charcoal.
  • While effective, the increased incidence of emesis with sorbitol warrants consideration in clinical decision-making.
Abstract

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...